Driven by her diagnosis with a Chiari malformation, Ashlyn Sanders founded NeuroVice in 2016, according to The Chronicle.
Here are five insights:
1. NeuroVice's mission is to develop devices that enhance the lives of those living with neurological disorders.
2. The company's team is working to develop a prototype called P.A.T.I., which is an oral device designed to stop patients from biting their tongues or hyper-salivating during seizures.
3. The company is aiming to fundraise $20,000 to complete a final design of the prototype.
4. The company has raised about $2,000 at this time.
5. Ms. Sanders graduated from Durham, N.C.-based Duke University in 2015 with a master of arts in bioethics and science policy.